Nanoform Finland Oyj (STO:NANOFS)
9.43
+0.23 (2.50%)
At close: Sep 1, 2025
Nanoform Finland Oyj Revenue
Nanoform Finland Oyj had revenue of 667.00K EUR in the quarter ending June 30, 2025, with 2.46% growth. This brings the company's revenue in the last twelve months to 3.95M, up 72.18% year-over-year. In the year 2024, Nanoform Finland Oyj had annual revenue of 3.66M with 42.70% growth.
Revenue (ttm)
3.95M EUR
Revenue Growth
+72.18%
P/S Ratio
17.63
Revenue / Employee
21.84K EUR
Employees
181
Market Cap
778.07M SEK
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.66M | 1.10M | 42.70% |
Dec 31, 2023 | 2.57M | -920.89K | -26.41% |
Dec 31, 2022 | 3.49M | 1.53M | 78.42% |
Dec 31, 2021 | 1.95M | 1.25M | 178.38% |
Dec 31, 2020 | 702.12K | 421.69K | 150.37% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |